Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
453.97
-5.61 (-1.22%)
Oct 8, 2025, 10:28 AM EDT - Market open
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
29
Consensus Rating
Strong Buy
Price Target
$448.97
Upside
-1.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $405 → $475 | Hold | Maintains | $405 → $475 | +4.63% | Oct 6, 2025 |
| Stifel | Stifel | Strong Buy Maintains $441 → $495 | Strong Buy | Maintains | $441 → $495 | +9.04% | Oct 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $435 → $500 | Buy | Maintains | $435 → $500 | +10.14% | Sep 19, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $453 → $520 | Strong Buy | Maintains | $453 → $520 | +14.55% | Sep 17, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $504 → $566 | Strong Buy | Maintains | $504 → $566 | +24.68% | Sep 16, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $280 → $515 | Buy | Maintains | $280 → $515 | +13.45% | Sep 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $450 → $470 | Buy | Maintains | $450 → $470 | +3.53% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $570 | Strong Buy | Reiterates | $570 | +25.56% | Sep 2, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $527 → $583 | Strong Buy | Maintains | $527 → $583 | +28.42% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $500 → $570 | Strong Buy | Maintains | $500 → $570 | +25.56% | Aug 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $348 → $475 | Buy | Maintains | $348 → $475 | +4.63% | Aug 6, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $490 | Hold → Buy | Upgrades | $490 | +7.94% | Aug 4, 2025 |
| Wolfe Research | Wolfe Research | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Aug 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $342 → $450 | Buy | Maintains | $342 → $450 | -0.87% | Aug 1, 2025 |
| UBS | UBS | Strong Buy Maintains $403 → $550 | Strong Buy | Maintains | $403 → $550 | +21.15% | Aug 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $390 → $415 | Strong Buy | Maintains | $390 → $415 | -8.58% | Aug 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.